
 
 
 
 
 
 
 
 
  WHAT IS CLAIMED IS:  
   
 1.    Method for promoting growth of an animal, said method comprising a gastro-intestinal tract delivery in said animal of an effective amount of live non-pathogenic Escherichia coli strain comprising F4 adhesins, and feeding said animal with a feed ration ad libitum, wherein said animal has increased growth compared to a control animal of similar age and condition, fed a similar feed ration ad libitum but which has not had said intestinal delivery.  
 
     
 2.    Method for reducing the feed conversion rate of an animal, said method comprising a gastro-intestinal tract delivery in said animal of an effective amount of live non-pathogenic Escherichia coli strain comprising F4 adhesins, and feeding said animal less food than is required to feed a control animal of similar age and condition but which has not had said intestinal delivery, to achieve the same growth.  
 
     
 3.    The method according to claim 1 or 2, wherein said delivery includes intestine delivery.  
 
     
 4.    The method according to any one of claims 1 to 3, wherein said delivery includes oral administration.  
 
     
 5.    The method according to claim 4, wherein said oral administration is via drinking water.  
 
     
 6.    The method according to any one of claims 1 to 5, wherein the delivery in said animal is during at least a part of the animal growing period.  
 
     
 7.    The method according to any one of claims 1 to 6, wherein said non-pathogenic Escherichia coli strain is delivered with a feed acceptable carrier.  
 
     
 8.    The method according to any one of claims 1 to 6, wherein said strain is in lyophilized form.  
 
     
 9.    The method according to claim 7, further comprising reconstituting the strain in said carrier prior to said delivery.  
 
     
 10.    The method according to claim 9, wherein the carrier includes water.  
 
     
 11.    The method according to claim 9, wherein the carrier includes milk.  
 
     
 12.    The method according to any one of claims 1 to 11, wherein the effective amount is of at least 5x 10 7 CFU per animal.  
 
     
 13.    The method according to any one of claims 1 to 11, wherein the effective amount is of from about 5x 10 7 to about 5x 10 9 CFU per animal.  
 
     
 14.    The method according to any one of claims 1 to 11, wherein the effective amount is of about 1 x 10 9 CFU per animal.  
 
     
 15.    The method according to any one of claims 1 to 11, wherein the effective amount is of about x 10 9 CFU per animal.  
 
     
 16.    The method according to any one of claims 1 to 15, wherein the non-pathogenic Escherichia coli strain comprising F4 adhesins is identical to the Escherichia coli strain deposited at the International Depository Authority of Canada (IDAC) on January 21, 2005 under accession number IDAC 210105-01.  
 
     
 17.    The method according to any one of claims 1 to 16, wherein the animal is reared for meat production.  
 
     
 18.    The method according to any one of claims 1 to 17, wherein the animal is a pig.  
 
     
 19.    The method according to any one of claims 1 to 17, wherein the animal is a post-weaning pig.  
 
     
 20.    The method according to claim 18 or 19, wherein the pig is aged from about 10 to about 28 days old.  
 
     
 21.    The method according to claim 18 or 19, wherein the pig is aged of 17 days old.  
 
     
 22.    The method according to any one of claims 1 to 17, wherein the animal is poultry.  
 
     
 23.    The method according to claim 22, wherein the poultry is chicken.  
 
     
 24.    The method according claim 22, wherein the poultry is a post-hatching chicken.  
 
     
 25.    The method according to any one of claims 22 to 24, wherein the poultry is aged from about 1 to about 7 days old.  
 
     
 26.    The method according to any one of claims 22 to 24, wherein the poultry is aged of 1 day old.  
 
     
 27.    The method according to any one of claims 1 to 16, wherein the animal is a mouse.  
 
     
 28.    The method according to any one of claims 1 to 16, wherein the animal is a post-weaning mouse.  
 
     
 29.    Isolated Escherichia coli strain identical to the Escherichia coli strain deposited at the International Depository Authority of Canada (IDAC) on January 21, 2005 under accession number IDAC 210105-01.  
 
     
 30.    A composition comprising a live non-pathogenic Escherichia coli strain comprising F4 adhesins and a feed acceptable carrier, the composition being adapted for gastro-intestinal tract delivery in an animal to reduce the feed conversion rate of the animal compared to a control animal of similar age and condition.  
 
     
 31.    A composition comprising a live non-pathogenic Escherichia coli strain comprising F4 adhesins and a feed acceptable carrier, the composition being adapted for gastro-intestinal tract delivery in an animal to promote growth of the animal compared to a control animal of similar age and condition.  
 
     
 32.    The composition of claim 30 or 31, being in lyophilized form.  
 
     
 33.    The composition of claim 30 or 31, wherein the carrier includes water.  
 
     
 34.    The composition of claim 30 or 31, wherein the carrier includes milk.  
 
     
 35.    The composition of any one of claims 30 to 34, the composition being adapted for delivery to the intestines.  
 
     
 36.    The composition of any one of claims 30 to 35, being adapted for oral administration.  
 
     
 37.    The composition of claim 36, the oral administration being via drinking water.  
 
     
 38.    The composition of any one of claims 30 to 37, wherein the strain is in an amount sufficient for administration of at least 5x 10 7 CFU per animal.  
 
     
 39.    The composition of any one of claims 30 to 37, wherein the strain is in an amount sufficient for administration of from 5 x 10 7 CFU to about 5 x 10 9 CFU per animal.  
 
     
 40.    The composition of any one of claims 30 to 37, wherein the strain is in an amount sufficient for administration of about 1 x 10 9 CFU per animal.  
 
     
 41.    The composition of any one of claims 30 to 37, wherein the strain is in an amount sufficient for administration of about 5 x 10 9 CFU per animal.  
 
     
 42.    The composition of any one of claims 30 to 41, wherein said non-pathogenic Escherichia coli strain is identical to the Escherichia coli strain deposited at the International Depository Authority of Canada (IDAC) on January 21, 2005 under accession number IDAC  210105-01.  
 
     
 43.    The composition of any one of claims 30 to 42, wherein the animal is reared for meat production.  
 
     
 44.    The composition of any one of claims 30 to 43, wherein the animal is a pig.  
 
     
 45.    The composition of any one of claims 30 to 43, wherein the animal is a post-weaning pig.  
 
     
 46.    The composition of claim 44 or 45, wherein the pig is aged from about 10 to about 28 days old.  
 
     
 47.    The composition of claim 44 or 45, wherein the pig is aged of 17 days old.  
 
     
 48.    The composition of any one of claims 30 to 43, wherein the animal is poultry.  
 
     
 49.    The composition of claim 48, wherein the poultry is a chicken.  
 
     
 50.    The composition of claim 48 or 49, wherein the poultry is aged from about 1 to about 7 days old.  
 
     
 51.    The composition of claim 48 or 49, wherein the poultry is aged of 1 day old.  
 
     
 52.    The composition of any one of claims 30 to 42, wherein the animal is a mouse.  
 
     
 53.    The composition of any one of claims 30 to 42, wherein the animal is a post-weaning mouse.  
 
     
 54. A product for gastro-intestinal tract delivery in an animal, said product comprising a live non-pathogenic Escherichia coli strain comprising F4 adhesins, the strain being in an amount sufficient for administration of at least 5 x 10 7 CFU per animal.  
 
     
 55.    The product of claim 54, wherein the product is in lyophilized form.  
 
     
 56.    The product of claim 54 or 55, wherein the product is for reconstitution in a carrier.  
 
     
 57.    The product of claim 56, wherein the carrier includes water.  
 
     
 58.    The product of claim 56, wherein the carrier includes milk.  
 
     
 59.    The product of any one of claims 54 to 58, wherein the product is for delivery to the intestines.  
 
     
 60.    The product of any one of claims 54 to 59, wherein the delivery includes oral administration.  
 
     
 61.    The product of claim 60, wherein the oral administration is via drinking water.  
 
     
 62. The product of any one of claims 54 to 61, the strain being in an amount sufficient for administration of from 5 x 10 7 CFU to about 5 x 10 9 CFU per animal.  
 
     
 63. The product of any one of claims 54 to 61, the strain being in an amount sufficient for administration of about 1 x 10 9 CFU per animal.  
 
     
 64. The product of any one of claims 54 to 61, the strain being in an amount sufficient for administration of about 5 x 10 9 CFU per animal.  
 
     
 65.    The product of any one of claims 54 to 64, wherein the animal is a pig.  
 
     
 66.    The product of any one of claims 54 to 64, wherein the animal is a post-weaning pig.  
 
     
 67.    The product of claim 65 or 66, wherein the pig is aged from about 10 to about 28 days old.  
 
     
 68.    The product of claim 67, wherein the pig is aged of 17 days old.  
 
     
 69.    The product of any one of claims 54 to 64, wherein the animal is poultry.  
 
     
 70.    The product of claim 69, wherein the poultry is a chicken.  
 
     
 71.    The product of claim 69 or 70, wherein the poultry is aged from about 1 to about 7 days old.  
 
     
 72.    The product of claim 71, wherein the poultry is aged of 1 day old.  
 
     
 73. A product for gastro-intestinal tract delivery in an animal, comprising a live non-pathogenic Escherichia coli strain comprising F4 adhesins, wherein the strain is in an amount sufficient to promote growth of the animal.  
 
     
 74.    The product of claim 73, wherein the product is in lyophilized form.  
 
     
 75.    The product of claim 73 or 74, wherein the product is for reconstitution in a carrier.  
 
     
 76.    The product of claim 75, wherein the carrier includes water.  
 
     
 77.    The product of claim 75, wherein the carrier includes milk.  
 
     
 78.    The product of any one of claims 73 to 77, wherein the product is for delivery to the intestines.  
 
     
 79.    The product of any one of claims 73 to 78, wherein the delivery includes oral administration.  
 
     
 80.    The product of claim 79, wherein the oral administration is via drinking water.  
 
     
 81. The product of any one of claims 73 to 80, the strain being in an amount sufficient for administration of from 5 x 10 7 CFU to about 5 x 10 9 CFU per animal.  
 
     
 82. The product of any one of claims 73 to 80, the strain being in an amount sufficient for administration of about 1 x 10 9 CFU per animal.  
 
     
 83. The product of any one of claims 73 to 80, the strain being in an amount sufficient for administration of about 5 x 10 9 CFU per animal.  
 
     
 84.    The product of any one of claims 73 to 83, wherein the animal is a pig.  
 
     
 85.    The product of any one of claims 73 to 83, wherein the animal is a post-weaning pig.  
 
     
 86.    The product of claim 84 or 85, wherein the pig is aged from about 10 to about 28 days old.  
 
     
 87.    The product of claim 86, wherein the pig is aged of 17 days old.  
 
     
 88.    The product of any one of claims 73 to 83, wherein the animal is poultry.  
 
     
 89.    The product of claim 88, wherein the poultry is a chicken.  
 
     
 90.    The product of claim 88 or 89, wherein the poultry is aged from about 1 to about 7 days old.  
 
     
 91.    The product of claim 90, wherein the poultry is aged of 1 day old.  
 
     
 92.    The product of any one of claims 54 to 91, wherein the strain is the Escherichia coli strain deposited at the International Depository Authority of Canada (IDAC) on January 21, 2005 under accession number IDAC 210105-01.  
 
     
 93.    A method of preparing a product for gastro-intestinal tract delivery in an animal, comprising: ¨    providing a sample including a non-pathogenic live non-pathogenic Escherichia coli strain comprising F4 adhesins; and ¨    lyophilizing said sample to obtain a lyophilized product, wherein said sample includes an amount sufficient of the strain to promote growth of the animal upon said gastro-intestinal tract delivery.  
 
     
 94.    The method of claim 93, further comprising reconstituting the lyophilized product in a carrier.  
 
     
 95.    The method of claim 94, wherein the carrier includes water.  
 
     
 96.    The method of claim 94, wherein the carrier includes milk.  
 
     
 97.    The method of any one of claims 93 to 96, wherein the product is for delivery to the intestines.  
 
     
 98.    The method of any one of claims 93 to 97, wherein the delivery includes oral administration.  
 
     
 99.    The method of claim 98, wherein the oral administration is via drinking water.  
 
     
 100. The method of any one of claims 93 to 99, wherein the strain is the Escherichia coli strain deposited at the International Depository Authority of Canada (IDAC) on January 21, 2005 under accession number IDAC 210105-01.  
 
   
 
 
 
 
 
 
 
 
